PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19874818-9	2010	Latrunculin B (disrupting actin cytoskeleton) and jasplakinolide respectively suppressed and enhanced the expression of VSMC markers, SRF, myocardin, and CArG-box-mediated SMC promoters in PAC1, a VSMC line.	jasplakinolide	50-64	serum response factor	Homo sapiens	134-137	
17332502-4	2007	A dramatic reduction of actin filament bundles is observed in ALP-antisense cells and treatment of these cells with the actin-stabilizing drug jasplakinolide stimulates SRF activity and restores the capacity of the cells to differentiate.	jasplakinolide	143-157	serum response factor	Homo sapiens	169-172	
15240009-9	2004	Treatment of OVCAR-3 cells with the F-actin stabilizing compound, jasplakinolide, prevented the protein kinase A (PKA)-mediated inhibition of SRF.	jasplakinolide	66-80	serum response factor	Homo sapiens	142-145